February 10, 2026
7:00pm
Coquette
Boston Seaport
Join two of biopharma’s most forward-thinking leaders in a candid, high-level conversation on the transformation of science in the era of AI. TetraScience CEO Patrick Grady is driving the replatforming of scientific data and workflows for AI-scale operations, while Anders Lindh is leading Mettler-Toledo's evolution toward intelligent, connected laboratory systems powered by applied AI. Together, they will explore how these foundational shifts are redefining R&D, manufacturing, and QC – looking ahead to 2026 and beyond.
This relaxed, off-the-record evening convenes a select group of senior biopharma R&D and QC leaders to exchange first-hand experiences, challenge conventional thinking, and discuss what it will take to industrialize scientific innovation at scale.
Why Attend
Engage directly with industry visionaries shaping the future of analytical labs
Exchange perspectives with senior R&D and QC leaders on AI, data, and automation challenges
Surface your toughest questions and boldest ideas in an intimate, off-the-record setting
No presentations. No sales pitches. Just candid dialogue and an exceptional dinner.
Hosted by
Patrick Grady, CEO, TetraScience
Anders Lindh, GM Global Business Area Analytical, Mettler-Toledo
Attendance is limited and by invitation only.
Please request to attend by February 4, 2026.
Fill out the form, and we'll save your spot.